Oluwaseun Egunsola
Safety of Levetiracetam in paediatrics: a systematic review
Egunsola, Oluwaseun; Choonara, Imti; Sammons, Helen Mary
Authors
Imti Choonara
Helen Mary Sammons
Abstract
Objective
To identify adverse events (AEs) associated with Levetiracetam (LEV) in children.
Methods
Databases EMBASE (1974-February 2015) and Medline (1946-February 2015) were searched for articles in which paediatric patients (≤18 years) received LEV treatment for epilepsy. All studies with reports on safety were included. Studies involving adults, mixed age population (i.e. children and adults) in which the paediatric subpopulation was not sufficiently described, were excluded. A meta-analysis of the RCTs was carried out and association between the commonly reported AEs or treatment discontinuation and the type of regimen (polytherapy or monotherapy) was determined using Chi2 analysis.
Results
Sixty seven articles involving 3,174 paediatric patients were identified. A total of 1,913 AEs were reported across studies. The most common AEs were behavioural problems and somnolence, which accounted for 10.9% and 8.4% of all AEs in prospective studies. 21 prospective studies involving 1120 children stated the number of children experiencing AEs. 47% of these children experienced AEs. Significantly more children experienced AEs with polytherapy (64%) than monotherapy (22%) (p<0.001). Levetiracetam was discontinued in 4.5% of all children on polytherapy and 0.9% on monotherapy (p<0.001), the majority were due to behavioural problems.
Conclusion
Behavioural problems and somnolence were the most prevalent adverse events to LEV and the most common causes of treatment discontinuation. Children on polytherapy have a greater risk of adverse events than those receiving monotherapy.
Citation
Egunsola, O., Choonara, I., & Sammons, H. M. (2016). Safety of Levetiracetam in paediatrics: a systematic review. PLoS ONE, 11(3), Article e0149686. https://doi.org/10.1371/journal.pone.0149686
Journal Article Type | Article |
---|---|
Acceptance Date | Feb 2, 2016 |
Publication Date | Mar 1, 2016 |
Deposit Date | Sep 27, 2016 |
Publicly Available Date | Sep 27, 2016 |
Journal | PLoS ONE |
Electronic ISSN | 1932-6203 |
Publisher | Public Library of Science |
Peer Reviewed | Peer Reviewed |
Volume | 11 |
Issue | 3 |
Article Number | e0149686 |
DOI | https://doi.org/10.1371/journal.pone.0149686 |
Public URL | https://nottingham-repository.worktribe.com/output/774258 |
Publisher URL | http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0149686 |
Contract Date | Sep 27, 2016 |
Files
PlosOne 2016 Levetiracetam Safety SR.PDF
(2 Mb)
PDF
Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by/4.0
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search